Turkmenistan Medical Device Compliance Calendar 2027: Annual Obligations and Scheduling
Updated: 2026-11-12 · GRZAN Regulatory Team · Verification date 2026-10-20
1. Key takeaways
Certificate holders in Turkmenistan face only four categories of annual actions, but each category has hard deadlines:
- Re-registration: the certificate is valid for 5 years, and the re-registration application must be submitted no later than 3 months before expiry;
- Change notifications: submitted within 30 calendar days of approval in the country of origin;
- Updates of the import document chain: TDS certification is handled per batch or per contract, and both the certification documents and the consular legalization documents have validity periods;
- Post-market vigilance: the registers of complaints and adverse events are maintained continuously as the data source for the safety report at re-registration.
The correct method for the annual schedule is: first build the countdown table from the certificate expiry date, then attach the other three categories of actions to it. Treating the four categories as a single calendar, rather than as four separate workstreams, is what keeps the certificate continuously valid and the shipments moving.
2. Legal basis
| Regulation | Reference number | Publication date | Provisions |
|---|---|---|---|
| Law of Turkmenistan on the Supply of Medicines | No. 319-V | January 12, 2016 | Validity of the registration certificate; re-registration; changes; suspension and cancellation |
| National Registration Regulation for Medicines and Medical Devices | No public number (approved by the Ministry of Health) | Current version | Re-registration documentation; change procedures |
| Law of Turkmenistan on Certification | No public number | Current version | Mandatory certification (TDS) |
3. Expert insights
Insight 1: The anchor of the annual schedule is the certificate expiry date, not the fiscal or calendar year.
Article 31 of this series explained that the validity period is 5 years, that re-registration must be submitted 3 months before expiry, and that the re-registration procedure takes 3 to 4 months. Setting checkpoints by counting back 12, 6 and 3 months from the expiry date is the only scheduling method that misses nothing, because it is derived from the legally fixed dates rather than from internal budget cycles. The countdown table should also record the responsible person for each checkpoint, so that the schedule survives staff changes.
Insight 2: The trigger for change notifications originates abroad, which makes it the easiest category to miss.
Article 33 of this series explained that the 30-day period runs from the day the change is approved in the country of origin. This means the trigger is not visible locally in Turkmenistan and can only be captured through a global change register maintained by the manufacturer and shared with the local representative. The register should record the approval date, the affected certificates and the planned submission date for Turkmenistan, all in one place.
Insight 3: The import document chain is the category that must be checked before every shipment.
TDS certification is handled per batch or per contract (Article 37 of this series), consular legalization documents have validity periods (Article 15), and remaining validity thresholds apply (Article 38). These three layers together mean that every shipment requires a document review before it can proceed, and the review should be embedded in the release process rather than left to memory. The review should be a fixed step in the shipment release checklist, with the sign-off recorded.
Insight 4: The vigilance register is the only category that is continuous and has no deadline.
Articles 41 and 42 of this series explained that the post-market surveillance details have not been published. Precisely because no reporting points are defined, the registers must be maintained continuously; otherwise the safety report required at re-registration cannot be prepared from evidence that covers the validity period of the certificate. A monthly entry routine, even in months when no events occurred, keeps the register demonstrably active.
Insight 5: Merging these four categories into one table is the deliverable at which this series converges.
The value of the fifty segments in this series should ultimately condense into a one-page schedule that the company can execute, with named owners and dates, rather than remain a collection of dispersed knowledge points that no one operationalizes. The table should be reviewed at each of the three countdown checkpoints and whenever a new entry is created in the global change register.
4. Practical recommendations
- Anchor the schedule on the certificate expiry date and set checkpoints at 12, 6 and 3 months.
- Maintain a global change register that captures the approval date in the country of origin to start the 30-day clock.
- Review three documents before every shipment: TDS certification, the validity of consular legalization documents and the remaining validity thresholds.
- Maintain the registers of complaints and adverse events continuously and connect them to the data for the re-registration report.
- Merge the four categories into a one-page annual schedule with responsibility assigned to named persons.
5. Verification checklist
- □ The certificate expiry date is registered and 12, 6 and 3 month checkpoints are set.
- □ A global change register exists and covers approval dates in the country of origin.
- □ The three-document review before shipment is embedded in the process.
- □ The registers of complaints and adverse events are maintained continuously.
- □ A one-page annual schedule has been prepared with responsibility assigned to persons.
Regulatory information verified as of October 30, 2026. The content cited in this document was checked against the Law on the Supply of Medicines No. 319-V (January 12, 2016, validity of the registration certificate, re-registration, changes, suspension and cancellation), the National Registration Regulation for Medicines and Medical Devices approved by the Ministry of Health and the Law on Certification (current versions). The re-registration procedure of 3 to 4 months and the change approval of 1 to 3 months are practical estimates; the remaining validity threshold of 60 percent (30 percent for short-dated products) was not obtained in official original text, and buffers must be reserved in scheduling with case-by-case confirmation.
- Local resources in Turkmenistan: GRZAN can coordinate licensed local import entities and authorized representative resources, covering state registration submission, the consular legalization chain for documents, sample delivery, coordination with mandatory TDS certification and customs clearance support.
- Service capabilities: classification determination, registration pathway selection, dossier preparation in the national format, consular legalization and notarization, test and stability documentation, GMP and ISO 13485 evidence organization, variations and re-registration, vigilance and post-market maintenance.
- Contact: info@grzanglobal.com. GRZAN provides registration support in this country for manufacturers, importers and authorized representatives.
Disclaimer
Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.
About GRZAN
GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.
GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.
Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.
What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.
Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.
Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.
Take your devices global with GRZAN
We work with manufacturers worldwide to open new markets with a clear regulatory pathway.
Contact us